Point-of-care blood chemistry, perfected
Piccolo Xpress (Abaxis) (abaxis.com) scores 71 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 25th percentile of 12056 Healthcare brands.
Piccolo Xpress is a point-of-care blood chemistry analysis system developed by Abaxis, an American medical technology company. It provides on-site, real-time bloodwork diagnostics through 17 complete chemistry panels and 31 tests, enabling healthcare providers to make faster clinical decisions. The technology originated from biochemical analysis methods developed for space-flight applications and is used by medical institutions seeking rapid, reliable diagnostic testing outside traditional laboratory settings.
| Brand Name | Piccolo Xpress (Abaxis) |
|---|---|
| Domain | abaxis.com |
| Industry | Healthcare, Technology |
| Parent Company / Owner | Abaxis |
| Main Competitors | IDEXX Laboratories (83/100), Abbott (i-STAT) (91/100), Siemens Healthineers (88/100), Roche Diagnostics, Heska (80/100), Ortho Clinical Diagnostics (75/100) |
Moz Domain Authority 43/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #335,978 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To deliver on-site, real-time bloodwork diagnostics that empower care providers to make faster, better decisions for their patients." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Facebook, Instagram; no detected presence on YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Piccolo Xpress (Abaxis)?", Claude could identify the brand as of September 2026. Piccolo Xpress is a point-of-care blood chemistry analyzer made by Abaxis, used in veterinary and human clinical settings to run rapid metabolic and chemistry panels from a small blood sample using disposable reagent discs. Best known for Portable point-of-care chemistry analyzer using single-use reagent discs for rapid blood panel results.
When asked "Best brands similar to Piccolo Xpress (Abaxis)?", Claude would recommend Piccolo Xpress (Abaxis) as of September 2026. It's a well established name in point-of-care chemistry testing, especially in veterinary diagnostics, so it's worth mentioning alongside similar analyzers like IDEXX Catalyst or i-STAT.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Piccolo Xpress (Abaxis)'s main competitors in Healthcare: IDEXX Laboratories (83/100), Abbott (i-STAT) (91/100), Siemens Healthineers (88/100), Heska (80/100), Ortho Clinical Diagnostics (75/100).
Sources: Brand Analyzer scan
Piccolo Xpress (Abaxis) has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 28, trust 26, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Piccolo Xpress offers a point-of-care blood chemistry analysis system that includes 17 complete chemistry panels and 31 individual tests. The product is designed to deliver on-site, real-time bloodwork diagnostics for use in medical practices and institutions, eliminating the need to send blood samples to external laboratories for chemistry testing.
Piccolo Xpress (Abaxis) scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Piccolo Xpress is a point-of-care blood chemistry analyzer developed by Abaxis, an American medical technology company. It is a diagnostic device designed to deliver on-site, real-time bloodwork results, allowing healthcare providers to obtain laboratory-quality chemistry results without sending samples to an off-site laboratory.
Piccolo Xpress (Abaxis) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Piccolo Xpress is known for being an early and original innovator in point-of-care blood chemistry testing, with technology originally derived from biochemical analysis methods developed for space-flight applications. It is recognized for offering a broad panel of 17 chemistry panels and 31 tests in a compact, on-site device used by medical institutions worldwide.
Piccolo Xpress is used by healthcare providers, medical practices, and institutions that require fast, reliable, on-site blood diagnostic testing for patient care. This includes clinical settings where immediate blood chemistry results support timely treatment decisions.
Piccolo Xpress (Abaxis) scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Piccolo Xpress (Abaxis) has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is trust (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #335,978 (Tranco) and a Moz Domain Authority of 43/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Piccolo Xpress (Abaxis) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Piccolo Xpress (Abaxis): Abax Health (71/100), AASRA (71/100), Abionic (71/100), AccentCare (71/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.